This will be the first systematic review of all types of
homeopathy for allergic rhinitis. We have attempted to
design a robust protocol which should result in an objective
and adequate summary of the available evidence
in this area of research. The review is not limited to
studies published in the English language: such limitation
might have excluded several studies that met all
other inclusion criteria. The selected databases index a
large number of CAM journals and the search strategy
is expected to identify most of the relevant studies that
exist.
Homeopathic treatment of patients with chronic sinusitis: A prospective obser...home
This observational study showed relevant improvements that persisted for 8 years
in patients seeking homeopathic treatment because of sinusitis. The extent to which the observed
effects are due to the life-style regulation and placebo or context effects associated with the
treatment needs clarification in future explanatory studies.
Homeopathic and conventional treatment for acute respiratory and ear complain...home
Data of 1,577 patients were evaluated in the full analysis set of which 857 received homeopathic (H) and 720
conventional (C) treatment. The majority of patients in both groups reported their outcome after 14 days of treatment
as complete recovery or major improvement (H: 86.9%; C: 86.0%; p = 0.0003 for non-inferiority testing). In the perprotocol
set (H: 576 and C: 540 patients) similar results were obtained (H: 87.7%; C: 86.9%; p = 0.0019). Further
subgroup analysis of the full analysis set showed no differences of response rates after 14 days in children (H: 88.5%; C:
84.5%) and adults (H: 85.6%; C: 86.6%). The unadjusted odds ratio (OR) of the primary outcome criterion was 1.40
(0.89–2.22) in children and 0.92 (0.63–1.34) in adults. Adjustments for demographic differences at baseline did not
significantly alter the OR. The response rates after 7 and 28 days also showed no significant differences between both
treatment groups. However, onset of improvement within the first 7 days after treatment was significantly faster upon
homeopathic treatment both in children (p = 0.0488) and adults (p = 0.0001). Adverse drug reactions occurred more
frequently in adults of the conventional group than in the homeopathic group (C: 7.6%; H: 3.1%, p = 0.0032), whereas in
children the occurrence of adverse drug reactions was not significantly different (H: 2.0%; C: 2.4%, p = 0.7838).
Systematic reviews of complementary therapies – an annotated bibliography. Pa...home
Complementary therapies are widespread but controversial. We aim to provide a
comprehensive collection and a summary of systematic reviews of clinical trials in three major
complementary therapies (acupuncture, herbal medicine, homeopathy). This article is dealing with
homeopathy. Potentially relevant reviews were searched through the register of the Cochrane
Complementary Medicine Field, the Cochrane Library, Medline, and bibliographies of articles and
books. To be included articles had to review prospective clinical trials of homeopathy; had to
describe review methods explicitly; had to be published; and had to focus on treatment effects.
Information on conditions, interventions, methods, results and conclusions was extracted using a
pretested form and summarized descriptively.
Epidemiology of Poisoning and Perception towards Poison Management Guidelin...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
Homeopathic treatment of patients with chronic sinusitis: A prospective obser...home
This observational study showed relevant improvements that persisted for 8 years
in patients seeking homeopathic treatment because of sinusitis. The extent to which the observed
effects are due to the life-style regulation and placebo or context effects associated with the
treatment needs clarification in future explanatory studies.
Homeopathic and conventional treatment for acute respiratory and ear complain...home
Data of 1,577 patients were evaluated in the full analysis set of which 857 received homeopathic (H) and 720
conventional (C) treatment. The majority of patients in both groups reported their outcome after 14 days of treatment
as complete recovery or major improvement (H: 86.9%; C: 86.0%; p = 0.0003 for non-inferiority testing). In the perprotocol
set (H: 576 and C: 540 patients) similar results were obtained (H: 87.7%; C: 86.9%; p = 0.0019). Further
subgroup analysis of the full analysis set showed no differences of response rates after 14 days in children (H: 88.5%; C:
84.5%) and adults (H: 85.6%; C: 86.6%). The unadjusted odds ratio (OR) of the primary outcome criterion was 1.40
(0.89–2.22) in children and 0.92 (0.63–1.34) in adults. Adjustments for demographic differences at baseline did not
significantly alter the OR. The response rates after 7 and 28 days also showed no significant differences between both
treatment groups. However, onset of improvement within the first 7 days after treatment was significantly faster upon
homeopathic treatment both in children (p = 0.0488) and adults (p = 0.0001). Adverse drug reactions occurred more
frequently in adults of the conventional group than in the homeopathic group (C: 7.6%; H: 3.1%, p = 0.0032), whereas in
children the occurrence of adverse drug reactions was not significantly different (H: 2.0%; C: 2.4%, p = 0.7838).
Systematic reviews of complementary therapies – an annotated bibliography. Pa...home
Complementary therapies are widespread but controversial. We aim to provide a
comprehensive collection and a summary of systematic reviews of clinical trials in three major
complementary therapies (acupuncture, herbal medicine, homeopathy). This article is dealing with
homeopathy. Potentially relevant reviews were searched through the register of the Cochrane
Complementary Medicine Field, the Cochrane Library, Medline, and bibliographies of articles and
books. To be included articles had to review prospective clinical trials of homeopathy; had to
describe review methods explicitly; had to be published; and had to focus on treatment effects.
Information on conditions, interventions, methods, results and conclusions was extracted using a
pretested form and summarized descriptively.
Epidemiology of Poisoning and Perception towards Poison Management Guidelin...iosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
A protocol for a trial of homeopathic treatment for irritable bowel syndromehome
Irritable bowel syndrome is a chronic condition with no known cure. Many sufferers seek
complementary and alternative medicine including homeopathic treatment. However there is much controversy as
to the effectiveness of homeopathic treatment. This three-armed study seeks to explore the effectiveness of
individualised homeopathic treatment plus usual care compared to both an attention control plus usual care and
usual care alone, for patients with irritable bowel syndrome.
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...home
Given the low number and included trials and the lowmethodological quality, any conclusion based on the resultsof this review have to be regarded as preliminary. However,as single case studies and clinical trials indicate a positiveeffect, homeopathy could be considered a complementarytreatment for patients with fibromyalgia
Advances in integrative nanomedicine for improving infectious disease treatme...home
Nanomedicine is integrative, blending modern technology with natural products to reduce toxicity and support immune function. Nanomedicine using traditional agents from alternative systems of medicine can facilitate progress in integrative public health approaches to infectious diseases.
Homeopathic and conventional treatment for acute respiratory and ear complain...home
This comparative cohort study, involving more than
1,500 patients in primary care practices of at least 6 different
European countries, demonstrates that homeopathic
treatment for acute respiratory and ear complaints was not
inferior to conventional treatment. Although no firm conclusions
can be drawn about the efficacy of homeopathic
treatment, these results certainly contribute to the growing
evidence that homeopathy is a safe and beneficial
treatment strategy for acute diseases in primary care settings.
Systematic reviews of complementary therapies – an annotated bibliography. Pa...home
Complementary therapies are widespread but controversial. We aim to provide a
comprehensive collection and a summary of systematic reviews of clinical trials in three major
complementary therapies (acupuncture, herbal medicine, homeopathy). This article is dealing with
homeopathy. Potentially relevant reviews were searched through the register of the Cochrane
Complementary Medicine Field, the Cochrane Library, Medline, and bibliographies of articles and
books. To be included articles had to review prospective clinical trials of homeopathy; had to
describe review methods explicitly; had to be published; and had to focus on treatment effects.
Information on conditions, interventions, methods, results and conclusions was extracted using a
pretested form and summarized descriptively.
Trends in management of rheumatoid arthritis Dr.Neena Mehan
Rheumatoid Arthritis (RA) is an auto-immune disease in which body mistakenly considers some parts of its own system as pathogens and attacks them.
A protocol for a trial of homeopathic treatment for irritable bowel syndromehome
Irritable bowel syndrome is a chronic condition with no known cure. Many sufferers seek
complementary and alternative medicine including homeopathic treatment. However there is much controversy as
to the effectiveness of homeopathic treatment. This three-armed study seeks to explore the effectiveness of
individualised homeopathic treatment plus usual care compared to both an attention control plus usual care and
usual care alone, for patients with irritable bowel syndrome.
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...home
Given the low number and included trials and the lowmethodological quality, any conclusion based on the resultsof this review have to be regarded as preliminary. However,as single case studies and clinical trials indicate a positiveeffect, homeopathy could be considered a complementarytreatment for patients with fibromyalgia
Advances in integrative nanomedicine for improving infectious disease treatme...home
Nanomedicine is integrative, blending modern technology with natural products to reduce toxicity and support immune function. Nanomedicine using traditional agents from alternative systems of medicine can facilitate progress in integrative public health approaches to infectious diseases.
Homeopathic and conventional treatment for acute respiratory and ear complain...home
This comparative cohort study, involving more than
1,500 patients in primary care practices of at least 6 different
European countries, demonstrates that homeopathic
treatment for acute respiratory and ear complaints was not
inferior to conventional treatment. Although no firm conclusions
can be drawn about the efficacy of homeopathic
treatment, these results certainly contribute to the growing
evidence that homeopathy is a safe and beneficial
treatment strategy for acute diseases in primary care settings.
Systematic reviews of complementary therapies – an annotated bibliography. Pa...home
Complementary therapies are widespread but controversial. We aim to provide a
comprehensive collection and a summary of systematic reviews of clinical trials in three major
complementary therapies (acupuncture, herbal medicine, homeopathy). This article is dealing with
homeopathy. Potentially relevant reviews were searched through the register of the Cochrane
Complementary Medicine Field, the Cochrane Library, Medline, and bibliographies of articles and
books. To be included articles had to review prospective clinical trials of homeopathy; had to
describe review methods explicitly; had to be published; and had to focus on treatment effects.
Information on conditions, interventions, methods, results and conclusions was extracted using a
pretested form and summarized descriptively.
Trends in management of rheumatoid arthritis Dr.Neena Mehan
Rheumatoid Arthritis (RA) is an auto-immune disease in which body mistakenly considers some parts of its own system as pathogens and attacks them.
Homeopathic medical practice: Long-term results of a cohort study with 3981 p...home
Disease severity and quality of life demonstrated marked and sustained
improvements following homeopathic treatment period. Our findings indicate that homeopathic
medical therapy may play a beneficial role in the long-term care of patients with chronic diseases.
Is there a role for Homeobotanicals in Conventional Medicine?Kimmer Collison-Ris
Homeobotanicals are scientifically prepared herbal formulas prepared in a laboratory in New Zealand and have been utilized for the last several decades by Naturopathic providers. These products have been created and tested for correct dosages and blended to become formulas for use in patient's healthcare. They were discovered by the late Dr. Brian Murray to use in patients who could not afford the expensive naturopathic treatments. This paper discusses their preparation, uses, and suggests that they could be complimentary in treating patients in conventional medicine where standard treatments have failed.
Homeopathic treatment of elderly patients - a prospective observational study...home
The severity of disease showed marked and sustained improvements under homeopathic treatment,
but this did not lead to an improvement of quality of life. Our findings might indicate that homeopathic medical
therapy may play a beneficial role in the long-term care of older adults with chronic diseases and studies on
comparative effectiveness are needed to evaluate this hypothesis.
Who seeks primary care for musculoskeletal disorders (MSDs) with physicians p...home
MSD patients consulting primary care physicians who prescribed homeopathy and CAMs differed
from those seen in conventional medicine. Chronic MSD patients represented a greater proportion of the clientele
in physicians offering alternatives to conventional medicine. In addition, these physicians treated chronic patients
as consulting rather than regular treating physicians, with potentially important impacts upon professional health
care practices and organisation.
Epidemiology is the study of occurrence, distribution and determinants of health and
diseases or disorders in man and its application in controlling health problems.
Epidemiology has by tradition two major areas.
First is the study of infectious diseases that spread to large populations, i.e., epidemics.
The second is the study of chronic diseases.
Epidemiological studies help to solve such health problems and provide a basis for
improving living conditions of the people.
During its progress and development, epidemiology has made available precise and
strict methodologies for the study of diseases.
Pharmacology is the study of the effects of drugs.
Clinical Pharmacology is the study of the effects of drugs in humans, It is traditionally
divided into two basic areas namely:
1. Pharmacokinetics
2. Pharmacodynamics.
Pharmacokinetics is the study of the relationship between dose administered of a drug
and the serum or blood level achieved, it deals with absorption, distribution, metabolism
and excretion.
Epidemiology is the study of the distribution and determinants of diseases in
populations.
Epidemics is the study of chronic/ infectious diseases in large populations.
Pharmacoepidemiology is the study of the use of and the effects of drugs in large
number of people.
It involves the examination of a single individual or large groups of people followed for
many years.
It involves gathering & analysis of information in order to identify possible causation &
related factors, that can be applied in clinical practice to group of people & also to
individuals undergoing treatment.
The international survey on the management of allergic rhinitis by physicians...Georgi Daskalov
ORIGINAL RESEARCH Open Access
The international survey on the management of
allergic rhinitis by physicians and patients
(ISMAR)
Carlos E Baena-Cagnani
1
†
ˆ
, Giorgio W Canonica
2*
, Mohamed Zaky Helal
3
†
, René Maximiliano Gómez
4
†
,
Enrico Compalati
2
†
, Mario E Zernotti
5
†
, Mario Sanchez-Borges
6
†
, Fabio F Morato Castro
7
†
,
Margarita Murrieta Aguttes
8
†
, Aida López-Garcia
9
†
, Faheem A Tadros
10
†
and ISMAR Study Group
Homeopahty, el proyecto de un Sistema de Salud, protagonistas, fundadores, ideólogos históricos, las iniciativas de Medicina Alternativa Complementaria CAM.
Homeopathy—quackery or a key to the future of medicine?home
When cholera first invaded Europe in 1831, the
mortality throughout Europe was generally between
40% and 60%. To the surprise of many, mortality
rates reported by homeopathic physicians was generally
below 10%, and commonly under 4%. Let me
present two typical cholera reports, which have a
stamp of officialdom. The first one comes from the
territory of Raab in Hungary where in 1831 a
Dr Joseph Bakody treated 223 patients with mild to
severe cholera, 14 of which were in a state of collapse .
He lost a total of 8 patients, a mortality of 3.6%. A
similar situation occurred in Cincinnati in 1849. The
Board of Health issued an order calling for physicians
to report all cases of cholera. Reports of a high
mortality rate were received by the Board from the city
hospital and allopathic physicians. However, six
homeopathic physicians attracted national attention
when they reported not a single death out of their first
350 cases of cholera. Two of these homeopathic
physicians, Dr Pulte and Ehrmann would eventually
report treating 2646 cases with 35 deaths, or a
mortality rate of 1.3%. Allopaths reported fatal
outcomes in about 50% of their cases.
Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...home
The use of antibiotics in the livestock sector is increasing to such an extent
that it threatens negative consequences for human health, animal health and the environment.
Homeopathy might be an alternative to antibiotics. It has therefore been tested in
a randomised placebo-controlled trial to prevent Escherichia coli diarrhoea in neonatal
piglets.
Multidrugresistant tuberculosis
Among the most menacing forms of MDR is multidrug
resistant tuberculosis (MDR-TB). WHO estimates that
were about 450,000 new cases and 170,000 deaths from
MDR-TB in 2012. The number of cases reported to
WHO rose by an alarming 35% between 2011 and 2012,
although this probably mostly reflects increased recognition
and reporting. Over half the new cases were in India,
China or the Russian Federation.3
This issue of Homeopathy features a paper by Dr Kusum
Chand and colleagues reporting a randomized, double blind,
placebo-controlled clinical trial of individualized homeopathic
treatment or placebo in addition to standard antituberculous
chemotherapy as specified by the Indian Revised
National Tuberculosis Control Program, for MDR-TB
articleHealth professionals’ and families’ understanding of the role ofindivi...home
This paper draws on a mixed methods study that examined the feasibility of conducting a randomised controlled trial of individualisedhomeopathy plus usual care, compared to usual care alone, for children aged 7–14 with moderate to severe asthma recruited from secondary care.It draws on qualitative interviews with participants in the feasibility study that investigated families’ and professionals’ views and experiences ofasthma, homeopathy and study participation
Cutting Edge Research in Homeopathy: HRI’s second international research conf...home
Rome, 3rde5th June 2015, was the setting for the Homeopathy Research Institute’s (HRI)
second conference with the theme ‘Cutting Edge Research in Homeopathy’. Attended by
over 250 delegates from 39 countries, this event provided an intense two and a half day
programme of presentations and a forum for the sharing of ideas and the creation of international
scientific collaborations. With 35 oral presentations from leaders in the field,
the scientific calibre of the programme was high and the content diverse. This report
summarises the key themes underpinning the cutting edge data presented by the
speakers, including six key-note presentations, covering advancements in both basic
and clinical research. Given the clear commitment of the global homeopathic community
to high quality research, the resounding success of both Barcelona 2013 and
Rome 2015 HRI conferences, and the dedicated support of colleagues, the HRI moves
confidently forward towards the next biennial conference
CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathyhome
The CORE-Hom database was created to answer the need for a reliable and publicly available
source of information in the field of clinical research in homeopathy. As of May 2014
it held 1048 entries of clinical trials, observational studies and surveys in the field of homeopathy,
including second publications and re-analyses. 352 of the trials referenced in
the database were published in peer reviewed journals, 198 of which were randomised
controlled trials. The most often used remedies were Arnica montana (n = 103) and
Traumeel (n = 40). The most studied medical conditions were respiratory tract infections
(n = 126) and traumatic injuries (n = 110). The aim of this article is to introduce
the database to the public, describing and explaining the interface, features and content
of the CORE-Hom database.
Observations about controlled clinical trials expressed by Max Haidvogl
in the book Ultra High Dilution (1994) have been appraised from a perspective two
decades later. The present commentary briefly examines changes in homeopathy
research evidence since 1994 as regards: the published number of randomised controlled
trials (RCTs), the use of individualised homeopathic intervention, the ‘proven efficacy of
homeopathy’, and the quality of the evidence.
Clinical trial of homeopathy in rheumatoid arthritishome
The conclusion of the study that the effect was due to
‘consultation’ and not to the homeopathic remedy appears
to be biased for two reasons:
There was no substantial amelioration of the pathology
in any group to compare and on which to base conclusions.
The placebo effect in such deep pathology cases is superficial
and transient as the patient remains in essence with
the same frame of pathology.
Blisters and homeopathy: case reports and differential diagnosishome
Blisters are skin lesions characterized by accumulation of fluid between the layers of the
skin. Their severity varies from the common blisters caused by friction to severe autoimmune
and congenital bullous disorders, some of themcurrently without treatment in conventional
medicine or requiring drugs with potentially severe side-effects. This article
reports cases of blistering diseases successfully treated with homeopathic medicines,
which represent an alternative for the treatment of such disorders.
A short history of the development of homeopathy in Indiahome
Homeopathy was introduced in India the early 19th century. It flourished in Bengal at first,
and then spread all over India. In the beginning, the system was extensively practised by
amateurs in the civil and military services and others. Mahendra Lal Sircar was the first
Indian who became a homeopathic physician. A number of allopathic doctors started
homeopathic practice following Sircar’s lead. The ‘Calcutta Homeopathic Medical
College’, the first homeopathic medical college was established in 1881. This institution
took on a major role in popularising homeopathy in India.
In 1973, the Government of India recognised homeopathy as one of the national systems of
medicine and set up the Central Council of Homeopathy (CCH) to regulate its education
and practice. Now, only qualified registered homeopaths can practice homeopathy in
India. At present, in India, homeopathy is the third most popular method of medical treatment
after allopathy and Ayurveda. There are over 200,000 registered homeopathic doctors
currently, with approximately 12,000 more being added every year.
Utilization of complementary and alternative medicine (CAM) among children fr...home
A homeopathy user utilized on average homeopathic remedies worth EUR 15.28. The corresponding figure for herbal
drug users was EUR 16.02, and EUR 18.72 for overall medicinal CAM users.
CAM use among 15-year-old children in the GINIplus cohort is popular, but decreased noticeably compared
with children from the same cohort at the age of 10 years. This is possibly mainly because German health legislation
normally covers CAM for children younger than 12 years only.
Complementary medical health services: a cross sectional descriptive analysis...home
The clinic attracts people from a wide area in the metropolitan Toronto and surrounding region with
health concerns and diagnoses that are consistent with primary care, providing health education and addressing
acute and chronic health conditions. Further explorations into health services delivery from the broader
naturopathic or other complementary/alternative medical professions would provide greater context to these
findings and expand understanding of the patients and type of care being provided by these health professionals.
Prayer-for-health and complementary alternative medicine use among Malaysian ...home
CAM use was prevalent among breast cancer patients. Excluding PFH from the definition of CAM
reduced the prevalence of overall CAM use. Overall, CAM use was associated with higher education levels and
household incomes, advanced cancer and lower chemotherapy schedule compliance. Many patients perceived
MBP to be beneficial for improving overall well-being during chemotherapy. These findings, while preliminary,
clearly indicate the differences in CAM use when PFH is included in, and excluded from, the definition of CAM
Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...home
The study shows that Gelsemium s., a medicinal plant used in traditional remedies and
homeopathy, modulates a series of genes involved in neuronal function. A small, but statistically significant,
response was detected even to very low doses/high dilutions (up to 30c), indicating that the human neurocyte
genome is extremely sensitive to this regulation.
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...home
These observations delineate the significance of immuno-modulatory circuit during calcarea carbonicamediated
tumor apoptosis. The molecular mechanism identified may serve as a platform for involving calcarea
carbonica into immunotherapeutic strategies for effective tumor regression
P05.39. Clinical experiences of homeopaths participating in a study of the ho...home
Homeopathic medications and dietary protocols were
found to be easily adapted for use in a clinical trial. These
observations provide insights for future research in the
area of homeopathic treatment (for ADHD in particular
and of homeopathy in general) and provide insights for
the potential integration of homeopathic practice into conventional
settings.
P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...home
The relationship between acupuncture use and depression
deserves further investigation. Given high levels of
concern about overuse of antibiotics in respiratory infections,
further research into the efficacy and cost-effectiveness
of homeopathy for these conditions is
warranted. Hopefully, future versions of NHIS-CAM
will provide more realistic estimates of expenditures.
P04.17. Adverse effects of homeopathy, what do we know? A systematic reviewhome
In order to prevent serious events as a consequence of
homeopathic treatment, the identification of an unwanted
adverse event is of critical importance. A differentiation of
adverse events and homeopathic aggravations, which is
accepted as a concept in homeopathy, should be a part of
a reporting system where risk and safety are assessed. This
is of particular significance in a treatment system like
homeopathy, which is in most European countries regulated
as an alternative treatment and as such not included
in the supervision system of health care.
P02.167. Long term evaluation of homeopathy on post treatment impairment of p...home
Homeopathy is effective in improving lung capacity and
health status. Benefits remain evident after a year. This
suggests that homeopathy could make an important
contribution to post treatment tuberculosis pulmonary
impairment
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. expenditure of one billion pounds in the National
Health Services in the United Kingdom [5]. Conven-
tional treatment includes oral or topical antihistamines,
intranasal or systemic corticosteroids, and allergen im-
munotherapy. A cohort of 16-year-olds in the United
Kingdom showed 23% to be suffering from hay fever in
1986 [6].
AR is also a global health problem, affecting 500 mil-
lion patients worldwide (10 to 20% of the population)
[7]. It may commonly be caused by house dust mites,
pollen from grass, trees and weeds, and animal dander.
AR can be broadly classified into seasonal and perennial.
AR has been found to significantly impair psychological
wellbeing and perceived to impair cognitive functioning
[8]. The prevalence of AR is also high in developing
nations: rhino-conjunctivitis was 15.3% amongst 11 to
15 year old school-going children in northern Africa [9].
In addition, there is growing evidence to support a link
between allergic rhinitis and asthma [10].
Several trials have evaluated the effectiveness of hom-
eopathy for AR. Results from these trials are mixed and
their quality is poor. One systematic review involving a
single homeopathic remedy (Galphimia glauca) for treat-
ing AR has been published in English [11]. Three out of
four studies included in that review reported significant
results in favor of the intervention, however, it only in-
cluded one homeopathic medicine. Two important draw-
backs of this review are that of the included trials, neither
used validated outcome measures nor intention-to-treat
analyses. Passalacqua et al. [12] conducted a systematic
review on complementary and alternative medicine for
rhinitis and asthma, concluding that the evidence for a
specific effect of homeopathy is weak. Bellavite et al.
[13] conducted a descriptive review of clinical research
on advances in homeopathy and immunology which
included AR. No meta-analysis was performed in this
review. Apart from Ernst [11], no systematic review
evaluating only homeopathic treatment for allergic
rhinitis has been published in English.
Why is it important to do this review?
No systematic review of all homeopathy modalities for
treating AR has been conducted. A problem with evaluat-
ing classical homeopathy is that it involves an extensive
consultation and an individualized treatment regimen.
Treatment regimens are decided based on disease state
and information gathered in the comprehensive homeo-
pathic case-taking by a qualified homeopathic physician.
Hence two patients with the same (conventional) diagno-
sis may receive very different homeopathic treatments.
Classical homeopathy therefore involves more extensive
consultations which themselves might have effects, at least
for subjective outcomes. Hence apparent positive effects
of classical homeopathy might be difficult to disentangle
from the effects of longer consultations and other ‘context
effects’ [14,15]. Clinical homeopathy, on the other hand, is
delivered in much the same way that conventional drugs
are prescribed. Complex homeopathy is similar to clinical
homeopathy but more than one remedy is prescribed in a
single formulation. Neither clinical nor complex homeop-
athy requires lengthy and comprehensive homeopathic
case-taking [16,17]. In both of these forms the interven-
tion is linked to a disease state and not individualized for
every patient. Clinical homeopathy, isopathy, and complex
homeopathy could also be more cost-effective and there-
fore more feasible in environments with limited resources
such as India.
A systematic review that includes clinical, complex
homeopathy and isopathy is therefore required to assess
the benefits of homeopathy for treating AR.
Methods/Design
Description of the intervention
The review will include trials of clinical, complex, isopathic,
and classical homeopathy. Homeopathic remedies are de-
fined as medicines listed in homeopathic materia medica
(texts containing symptoms of homeopathic remedies) and
prepared according to the homeopathic pharmacopoeia of
the country in which the trial is being conducted.
Objective
Our primary objective is to determine the efficacy and
effectiveness of homeopathic treatment of AR. Our sec-
ondary aim is to compare the effectiveness of different
forms of homeopathy on AR.
Criteria for including studies for this review
Types of studies
Randomized, double-blinded (both patients and doctors
blinded), controlled trials comparing homeopathy (clas-
sical, clinical, isopathic, or complex) with conventional
treatment, other homeopathy, or placebo, for the treat-
ment of seasonal or perennial AR in patients of any
age.
Types of participants
All age groups (newborn to adult) suffering from any
form of AR will be included. These may include partici-
pants with acute or chronic comorbidities but without
immunodeficiency. Participants may also include those
on conventional treatment for other health issues. Symp-
toms of allergic rhinitis include rhinorrhea, nasal obstruc-
tion, nasal itching, and sneezing which are reversible
spontaneously or with treatment [2]. A diagnosis of AR
will include the following symptoms based on the Guideline
Summary of Management of Allergic and Non Allergic
Rhinitis [7]:
Banerjee et al. Systematic Reviews 2014, 3:59 Page 2 of 6
http://www.systematicreviewsjournal.com/content/3/1/59
3. Nose: nasal discharge (runny nose),sneezing, nasal
blockage or congestion, and itchy nose and palate. Eye:
bilateral itchy eyes, red eyes (concomitant allergic con-
junctivitis), and swollen eyes.
There is no specific duration of symptoms required for
diagnosis; however, a very short or non-repetitive history
of symptoms generally excludes a diagnosis of AR. The
presence of any one of the nasal symptoms will be es-
sential for a diagnosis of AR except when nasal blockage
is the only symptom. Nasal blockage on its own rarely
indicates allergy [2]. The duration of symptoms will not
be present as a criterion since this has not been defined
for a diagnosis of AR.
Exclusion criteria for systematic review
The exclusion criteria for this review are as follows: con-
ference proceedings and other abstracted articles in which
risk-of-bias assessments cannot usefully be applied; studies
in which a non-randomized method of sequence gener-
ation and/or a single-blinded approach is explicitly used
by the authors; studies using formulations not described
by the authors as ‘homeopathic’; studies with a crossover
trial design; and studies in which homeopathy is combined
with another intervention.
The exclusion criteria for quantitative data extraction
(for meta-analysis are: studies from which no data are pro-
vided or data are otherwise not extractable. The latter cat-
egory includes studies with continuous outcomes from
which standard deviations are not derivable and those that
report non-parametric data only.
Investigations
Investigations are not always required to confirm diagno-
sis. However, a confirmation of allergic rhinitis sometimes
involves a skin prick test and/or specific and serum total
IgE tests [18]. The use of investigations for confirming
diagnosis will not be an inclusion criterion. Trials allowing
the administration of conventional treatment as a rescue
medication will be included.
Types of interventions
We will include trials involving experimental homeopathic
treatments delivered orally, through olfaction, or applied
on the body. Therefore, globules, nasal sprays, ointments,
and other applications prepared with homeopathic medi-
cines will be included in this review. In these trials the
homeopathic preparations may contain a single medicine
or more than one medicine as in complex homeopathy,
the homeopathic interventions may be administered as
one single preparation or more than one preparation, and
the comparators in the included trials will be placebos or
conventional treatment which may include antihistamines,
immunotherapy, and decongestants and so forth.
The alleged difference between homeopathy type
(classical, clinical, and complex) is important and might
be inadequately reported. To deal with this we will use
two strategies. First, we will examine individual studies
to verify the classification of homeopathy type (classical,
clinical, complex, or isopathy) using standard defini-
tions [16]. These are:
‘Classical [individualized] homeopathy: When a single
homeopathic remedy was selected based on the total
symptom picture of a patient.
Clinical homeopathy: When one or several single
remedies were administered for standard clinical
situations or conventional diagnoses.
Complex homeopathy: When multiple remedies were
mixed into a standard formula to ‘cover’ a person’s
symptoms and diagnoses.
Isopathy: When serial agitated dilutions were made
from the causative agent in an infectious or
toxicological condition’ (from Linde et al. [16]).
Therefore when classical homeopathy is used, any
homeopathic medicine may be selected based on com-
prehensive case taking. In clinical homeopathy, for ex-
ample, Allium cepa (a common homeopathic remedy
from onions) may be prescribed based on indications
that match the clinical picture of allergic rhinitis. In
complex homeopathy a preparation containing Luffa oper-
culata, Galphimia glauca, Histamine and Sulphur [19]
may be used to treat AR.
A preparation from an allergen such as Betula (birch)
[20] is an example of an isopathic intervention for AR.
In practice, medicines used by clinical homeopaths may
also be prescribed by classical homeopaths should they
be indicated after comprehensive case-taking. By classi-
fying included studies according to type of homeopathy,
this review will inform practitioners for the first time
about homeopathic medicines according to homeopathy
type for AR.
The current authors’ classification, made according to
these published definitions, will override reported clas-
sifications where appropriate. Second, we will conduct a
subgroup analysis to detect any differences between
homeopathy types for any outcome measure. If a particu-
lar type fails to demonstrate a statistically significant bene-
fit over another then the debate over homeopathy types
becomes moot. On the other hand, if we do find a statisti-
cally significant difference in effects then we will have
shown the importance of specifying homeopathy type.
There will be no limit on the maximum dilution of the
homeopathic medicine. Trials with homeopathic ‘mother
Banerjee et al. Systematic Reviews 2014, 3:59 Page 3 of 6
http://www.systematicreviewsjournal.com/content/3/1/59
4. tinctures’ will be included in this review as part of sub-
group analyses (see below).
Primary outcomes
The primary outcomes of this review are as follows: the
improvement of global symptoms recorded in validated
daily or weekly diaries and any scores from validated visual
analogue scales; the total Quality of Life Score (such as the
Juniper RQLQ); individual symptoms scores which include
any appropriate measures of nasal obstruction, runny
nose, sneezing, itching, and eye symptoms; and the num-
ber of days requiring medication. In case of child partici-
pants, AR symptoms rated by parents will be considered
acceptable.
Secondary outcomes
The secondary outcomes of this review are as follows:
IgE levels, individual ocular symptoms, any adverse event,
hospitalization due to an adverse event, and use of con-
ventional medication (frequency and quantity).
Search
Electronic search
The search to locate randomized trials will be based
on the Cochrane Highly Sensitive Search Strategy [21].
Manual search of the results will supplement the elec-
tronic search.
Medline (1946 to December 2013 inclusive) on Ovid,
CENTRAL, The Cochrane Ear Nose and Throat Disorder
Group Trials Register, CINAHL, EMBASE (1974 to
December 2013) on Ovid, Allied and Complementary
Medicine Database (AMED) (1985 to December 2013)
on Ovid, CAM-Quest and Google Scholar.
The search will not have any language filters. The refer-
ence lists of identified studies will be searched for add-
itional trials and trial authors will be contacted if data are
missing from reports of studies. Filters for randomized
controlled trials, human trials, and so forth will not be
applied.
The search strategy that will be used to search Medline
and adapted for the other sources is detailed in Table 1.
Bibliographies of identified studies and reviews will be
hand searched.
Selection of studies
Studies will be eligible for inclusion if they have a random-
ized, blinded and controlled design, validated measures of
outcome, and evaluate homeopathic treatment for AR.
Two review authors (KB and JH) will independently
review titles and abstracts to select potentially eligible
studies. This will be followed by a full text analysis of
the selected studies to assess compliance with the eligibil-
ity criteria. Disagreements will be resolved by discussion
first. A third author (CC) will arbitrate if the disagreement
is due to a difference in interpretation. If no clear
categorization can be made of a selected study it will be
categorized as one that is awaiting assessment. Study au-
thors will be contacted for further information wherever
necessary. RTM may be asked to categorize the study. The
selected studies will then be further evaluated for meth-
odological quality (risk of bias).
Data extraction and management
A data extraction form will be designed and the relevant
details will be transferred to the standard data extraction
sheet after the form is reviewed by all authors. This will
cover study type and methods including number and de-
scription of participants; details of type, mode of admin-
istration, dosage, and duration of intervention; and type,
timing, and measurement method of outcomes. The au-
thors, publication year, and journal of publication will
also be recorded. Two review authors (KB and RTM)
will independently extract data from every included trial
to minimize error and reduce potential bias.
Assessment of risk of bias in included studies
Two review authors (KB and JH) will independently as-
sess the risk of bias of each study using the Cochrane
Risk of Bias Tool from the Cochrane Handbook for Sys-
tematic Reviews of Intervention [22]. These consist of
sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome
Table 1 Search strategy: homeopathy for allergic rhinitis
Step Search procedure
1 Homeopathy/
2 (Homoeopathy or homoeopathic or homeopathic).mp. [mp =
title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary
concept, rare disease supplementary concept, unique identifier]
3 1 or 2
4 Rhinitis, Allergic, Perennial/or Rhinitis, Vasomotor/or Rhinitis/or
Rhinitis, Atrophic/or Rhinitis, Allergic, Seasonal/
5 (nasal congestion or rhinorrhea or rhinorrhea or sneezing or itchy
nose).mp. [mp = title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol
supplementary concept, rare disease supplementary concept,
unique identifier]
6 Exp Rhinitis/
7 (rhiniti* or rhinoconjunctivitis or SAR or PAR).mp. [mp = title,
abstract, original title, name of substance word, subject heading
word, keyword heading word, protocol supplementary concept,
rare disease supplementary concept, unique identifier]
8 (hay fever or hay next fever or pollinosis or pollenosis).mp. [mp =
title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary
concept, rare disease supplementary concept, unique identifier]
9 4 or 5 or 6 or 7 or 8
10 3 and 9
Banerjee et al. Systematic Reviews 2014, 3:59 Page 4 of 6
http://www.systematicreviewsjournal.com/content/3/1/59
5. assessment, incomplete outcome data, selective out-
come reporting, and other sources of bias.
Each of these factors will be described as reported in
the trial. Attributes of ‘low’, ‘high’, or ‘unclear’ risk will be
made for each of them. We will resolve any disagree-
ments about inclusion of a study by discussion and
consensus first. A third reviewer (CC or RTM) will ar-
bitrate if disagreement is due to difference in interpret-
ation. Trial authors will be contacted if clarification is
required.
Measurement of treatment effect
Baseline comparability of treatment groups for known
prognostic variables will be assessed. For continuous
data, individual and pooled statistics as mean difference
and standardized mean difference with 95% CI will be
calculated. In case of dichotomous outcomes, risk ratios
(or, if feasible, odds ratios) will be calculated with 95%
CI. If appropriate, meta-analysis will be performed after
assessment of clinical or statistical heterogeneity. The in-
dividual participant will be the unit of analysis. Descrip-
tive information on missing data will be included about
participants missing due to dropout, whether there was
intention-to-treat or per-protocol analysis, and about
missing statistics.
Assessment of heterogeneity and reporting biases
Heterogeneity will be assessed by comparing trial popu-
lations, settings, and methods. Statistical heterogeneity
will be assessed using the I2
statistic. A value of greater
than 50% will be considered as important heterogeneity.
Both fixed-effect and random-effect models will be ap-
plied to the data. If the fixed effect and random effect
meta-analyses give identical results then it is unlikely
that there is important statistical heterogeneity, and the
fixed-effect result will be presented. If the results vary,
possible causes of heterogeneity will be examined. This
will inform which result should be reported - stable robust
techniques with an underlying assumption of a fixed effect
(which may be incorrect) or less stable, sometimes unpre-
dictable techniques based on an underlying assumption of
random effect (which may be more likely). A sensitivity
analyses will be performed by conducting the meta-
analysis including and excluding studies which were
deemed to affect heterogeneity. Changes, if any, will be
reported in a table. Funnel plots will be constructed, if
possible. This is a scatter plot of the intervention effect
estimates from individual studies against some measure
(usually the standard error of the mean) of each study’s
sample size or precision.
Data synthesis
Review Manager (RevMan) [Computer program], Ver-
sion 5.2. Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration, 2012. RevMan 5.2 will be
used for data synthesis and meta-analysis. The primary
analyses are homeopathy (all forms) compared with pla-
cebo, and homeopathy (all forms) compared with con-
ventional treatment. The additional analyses are: (1)
clinical homeopathy compared with placebo; (2) clinical
homeopathy compared with conventional treatment; (3)
complex homeopathy compared with placebo; (4) com-
plex homeopathy compared with conventional treat-
ment; (5) classical homeopathy compared with placebos;
and (6) classical homeopathy compared with conventional
treatment. We shall compare the pooled effect sizes of: #1
and #3 and #5; #2 and #4 and #6.
Subgroup analyses
If sufficient data are available, subgroup analyses will be
conducted to investigate the effect of homeopathic po-
tency (mother tincture; potency <12C; potency >12C);
different age groups (children versus adults) and differ-
ent types of AR (perennial versus seasonal). It is recog-
nized that there will be relatively low power to detect
effects at the subgroup level; hence these analyses will
be undertaken with the aim of hypothesis generation
only.
Sensitivity analyses
A sensitivity analysis will be performed to explore the
impact of risk-of-bias on overall treatment effect. Studies
will be pooled according to low, uncertain or high risk
of bias. The contribution of studies to heterogeneity will
be assessed.
Discussion
This will be the first systematic review of all types of
homeopathy for allergic rhinitis. We have attempted to
design a robust protocol which should result in an ob-
jective and adequate summary of the available evidence
in this area of research. The review is not limited to
studies published in the English language: such limita-
tion might have excluded several studies that met all
other inclusion criteria. The selected databases index a
large number of CAM journals and the search strategy
is expected to identify most of the relevant studies that
exist.
Abbreviations
AMED: Allied and Complementary Medicine Database; AR: Allergic Rhinitis;
CAM: Complementary and Alternative Medicine; IgE: Immunoglobulin E.
Competing interests
The authors declare that there are no competing interests.
Authors’ contributions
KB conceived of the review, designed, and wrote the protocol. KB will carry
out the searches, extract data, conduct risk-of-bias assessment, carry out the
meta-analysis, draw the conclusions, and write the manuscript for the review.
JH edited the protocol, will carry out the searches, extract data, conduct
Banerjee et al. Systematic Reviews 2014, 3:59 Page 5 of 6
http://www.systematicreviewsjournal.com/content/3/1/59
6. risk-of-bias assessment, will draw conclusions, and edit the manuscript for
the review. CC and RTM edited the protocol, will resolve issues relating to
inclusion of studies, risk-of-bias assessment, and conclusions. CC and RTM
will assist KB with meta-analysis and edit the manuscript. All authors have
approved the protocol. All authors read and approved the final manuscript.
Authors’ information
KB is a homeopath practicing in New Delhi, India and has completed the
coursework for a Master of Science in Evidence Based Healthcare from the
University of Oxford. JH is a senior research associate at the University of
Oxford.CC is lecturer in medical statistics at the Clinical Trials Unit at the
Queen Mary University of London.RTM is the Research Development Adviser
of the British Homeopathic Association, UK.
Acknowledgements
The authors would like to acknowledge the contribution of Professor George
Lewith in editing this protocol.
Author details
1
Dr. Kalyan Banerjee’s Clinic, I-1691 Chittaranjan Park, New Delhi 110019,
India. 2
Centre for Primary Care and Public Health, Blizard Institute, Yvonne
Carter Building, 58 Turner Street, London E1 2AB, UK. 3
British Homeopathic
Association and Faculty of Homeopathy, Hahnemann House, 29 Park Street
West, Luton, Bedfordshire LU1 3BE, UK. 4
Centre for Evidence-Based Medicine,
Department of Primary Care Health Sciences University of Oxford, New Rad-
cliffe House, 2nd floor, Jericho, Oxford OX2 6NW, UK.
Received: 28 January 2014 Accepted: 23 May 2014
Published: 10 June 2014
References
1. Angier E, Willington J, Scadding G, Holmes S, Walker S: Management of
allergic and non-allergic rhinitis: a primary care summary of the BSACI
guideline. Prim Care Respir J 2010, 19:217–222.
2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T,
Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert
C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y,
Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O,
Kaliner MA, Kim YY, Kowalski ML: Allergic Rhinitis and its Impact on Asthma
(ARIA) 2008 update (in collaboration with the World Health Organization,
GA(2)LEN and Aller Gen). Allergy 2008, 63:8–160.
3. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A: Seasonal
allergic rhinitis is associated with a detrimental effect on examination
performance in United Kingdom teenagers: case-control study. J Allergy
Clin Immunol 2007, 120:381–387.
4. Malone DC, Lawson KA, Smith DH, Michael Arrighi H, Battista C: A cost of
illness study of allergic rhinitis in the United States. J Allergy Clin Immunol
1997, 99:22–27.
5. Gupta R, Sheikh A, Strachan DP, Anderson HR: Time trends in allergic
disorders in the UK. Thorax 2007, 62:91–96.
6. Butland BK, Strachan DP, Lewis S, Bynner J, Butler N, Britton J: Investigation
into the increase in hay fever and eczema at age 16 observed between
the 1958 and 1970 British birth cohorts. BMJ 1997, 315(7110):717–721.
7. Brożek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB,
van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ: Allergic Rhinitis and its
Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol
2010, 126:466–476.
8. Kremer B, Den Hartog HM, Jolles J: Relationship between allergic rhinitis,
disturbed cognitive functions and psychological well-being. Clin Exp
Allergy 2002, 32:1310–1315.
9. Georgy V, Fahim HI, El Gaafary M, Walters S: Prevalence and
socioeconomic associations of asthma and allergic rhinitis in northern
Africa. Eur Respir J 2006, 28:756–762.
10. Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P,
Bousquet J: Allergic rhinitis, rhinosinusitis, and asthma: one airway
disease. Immunol Allergy Clin North Am 2004, 24:19–43.
11. Ernst E: Homeopathic Galphimiaglauca for hay fever: a systematic review
of randomized clinical trials and a critique of a published meta‐analysis.
Focus Altern Compl Ther 2011, 16:200–203.
12. Passalacqua G, Bousquet PJ, Carlsen K-H, Kemp J, Lockey RF, Niggemann B,
Pawankar R, Price D, Bousquet J: ARIA update: I—Systematic review of
complementary and alternative medicine for rhinitis and asthma.
J Allergy Clin Immunol 2006, 117:1054–1062.
13. Bellavite P, Marzotto M, Chirumbolo S, Conforti A: Advances in
homeopathy and immunology: a review of clinical research. Front Biosci
(Schol Ed) 2011, 3:1363–1389.
14. Nuhn T, Lüdtke R, Geraedts M: Placebo effect sizes in homeopathic
compared to conventional drugs – a systematic review of randomized
controlled trials. Homeopathy 2010, 99:76–82.
15. Spence D: Good medicine: homeopathy. BMJ 2012, 345:e6184.
16. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB:
Are the clinical effects of homoeopathy placebo effects? A meta-analysis
of placebo-controlled trials. Lancet 1997, 350:834–843.
17. Shang A, Huwiler-Müntener K, Nartey L, Jüni P, Dörig S, Sterne JAC, Pewsner
D, Egger M: Are the clinical effects of homoeopathy placebo effects?
Comparative study of placebo-controlled trials of homoeopathy and
allopathy. Lancet 2005, 366:726–732.
18. Al Sayyad Jamal J, Fedorowicz Z, Alhashimi D, Jamal A: Topical nasal
steroids for intermittent and persistent allergic rhinitis in children.
Cochrane Database Syst Rev 2007, (1). doi:10.1002/14651858.CD003163.pub4.
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003163.pub4/full.
19. Weiser M, Gegenheimer LH, Klein P: A randomized equivalence trial
comparing the efficacy and safety of Luffa comp.-Heel Nasal Spray with
cromolyn sodium spray in the treatment of seasonal allergic rhinitis.
Forsch Komplementarmed 1999, 6:142–148.
20. Aabel S: No beneficial effect of isopathic prophylactic treatment for birch
pollen allergy during a low-pollen season: a double-blind, placebo-
controlled clinical trial of homeopathic Betula 30c. Br Homoeopath J 2000,
89:169–173.
21. Lefebvre C, Manheimer E, Glanville J: Searching for Studies. Cochrane
Handbook for Systematic Reviews of Interventions. New York: Wiley;
2008:95–150.
22. Higgins J, Altman DG: Chapter 8: Assessing risk of bias in included
studies. In Cochrane Handbook for Systematic Reviews of Interventions. Edited
by Higgins JP, Green S. Chichester (UK): John Wiley & Sons; 2008.
doi:10.1186/2046-4053-3-59
Cite this article as: Banerjee et al.: Homeopathy for allergic rhinitis:
protocol for a systematic review. Systematic Reviews 2014 3:59.
Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit
Banerjee et al. Systematic Reviews 2014, 3:59 Page 6 of 6
http://www.systematicreviewsjournal.com/content/3/1/59